Genflow Biosciences: Funding, Investors & Team (Sep 2026)
GenFlow Biosciences is a synthetic biology corporation that creates gene therapies to delay or stop the aging process in both humans and canines. It is committed to the development and promotion of creative therapies that target aging in both humans and animals. Its main goals are extending life expectancy and creating treatments that can fight off diseases that are brought on by aging and advanced age.
Genflow Biosciences has raised $10.7M across 6 funding rounds on record, the most recent an undisclosed round of $1.1M announced in Mar 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genflow Biosciences Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Genflow Biosciences Funding Rounds
Genflow Biosciences raised $900k in an undisclosed round announced in Apr 2024.
6 months later, an undisclosed round of $3.0M was announced in Oct 2024.
7 months later, an undisclosed round of $670k was announced in May 2025.
2 months later, an undisclosed round of $4.6M was announced in Jul 2025.
3 months later, an undisclosed round of $460k was announced in Oct 2025.
5 months later, an undisclosed round of $1.1M was announced in Mar 2026.
Genflow Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Genflow Biosciences Funding Compared to Other Biotechnology Startups
Genflow Biosciences' latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genflow Biosciences in Biotechnology and Cambridge
Companies Similar to Genflow Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Genflow Biosciences Funding FAQs
What does Genflow Biosciences do?
GenFlow Biosciences is a synthetic biology corporation that creates gene therapies to delay or stop the aging process in both humans and canines. It is committed to the development and promotion of creative therapies that target aging in both humans and animals. Its main goals are extending life expectancy and creating treatments that can fight off diseases that are brought on by aging and advanced age.
How much funding has Genflow Biosciences raised?
Genflow Biosciences has raised $10.7M across 6 rounds on record. The most recent is an undisclosed round of $1.1M announced in Mar 2026.
When did Genflow Biosciences last raise funding?
Genflow Biosciences' most recent funding round on record is an undisclosed round of $1.1M, announced in Mar 2026.
Who founded Genflow Biosciences?
FundedIQ lists Eric Leire (Founder) at Genflow Biosciences.
Where is Genflow Biosciences headquartered?
Genflow Biosciences is based in Cambridge, Massachusetts, United States.
How many employees does Genflow Biosciences have?
Genflow Biosciences is in the 1-10 employee band.
How does Genflow Biosciences' funding compare to other Biotechnology startups?
Genflow Biosciences' latest round of $1.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Genflow Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genflow Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.